State Closes Another Watertown Smoke Shop Over Youth-Targeted Products
Illegal cannabis retail enforcement remains a critical issue as state agencies close shops selling products appealing to children. These enforcement actions highlight ongoing challenges in cannabis retail regulation. Clinicians should be aware of the…
Charlotte Dispensary Expansion Amid Hemp-Derived THC Regulatory Uncertainty
Hemp-derived THC products regulatory gray zone creates clinical uncertainty for patients and clinicians. The expansion of unregulated THC retail highlights risks in product safety and dosing. Clinicians must proactively discuss hemp-derived THC products…
After Federal Court Win, Oklahoma Medical Marijuana Operators Fight State
Oklahoma medical marijuana legal challenges have intensified after a federal court victory for operators. These legal disputes focus on state regulatory overreach affecting patient access. Clinicians should monitor these developments as they impact the…
The Impact of Rescheduling Cannabis on Federal Research Changes
Rescheduling cannabis research federal changes remove significant barriers to clinical trials. This shift enables physicians to rely on evidence-based data for prescribing decisions. It marks a critical move toward advancing patient care and expanding…
Cannabinoid-Based Symptom Management in Clinical Practice
This article collection focuses on cannabinoid-based symptom management and its evolving clinical relevance. Recent developments highlight regulatory challenges and market dynamics. Clinicians must navigate these complexities carefully.
Challenges in Cannabis Impairment Detection for Driving Safety
Cannabis impairment detection remains a critical challenge in driving safety enforcement. This case highlights the risks of cannabis intoxication on motor function and judgment. Clinicians should counsel patients on cannabis use and driving safety.
How Rescheduling Will Impact Cannabis Intellectual Property Valuations
Cannabis intellectual property valuation will significantly shift following federal rescheduling, reshaping medical cannabis operators' asset pricing. This change primarily impacts pharmaceutical-grade cannabis products developed under strict research…
Limited Doctors and Long Drives Challenge Medical Cannabis Patients
Medical cannabis physician scarcity is a major barrier for patients seeking care in Alabama. Limited provider availability forces patients to travel long distances, delaying treatment. This scarcity highlights the need for more clinicians trained in…
How Federal Rescheduling Could Influence Tennessee Medical Cannabis Legalization
Tennessee medical cannabis legalization prospects are evolving with federal rescheduling discussions. This shift could allow clinicians to recommend cannabis legally, expanding treatment options. Tennessee healthcare providers should stay informed about…
Texas Set to Ban Smokable Hemp THC Flower by March 31
The Texas hemp smokable THC ban will take effect on March 31, changing how hemp-derived THC flower is regulated. This policy impacts clinicians' ability to recommend smokable hemp products. Patients using these products should be counseled on…